InMed Pharmaceuticals Inc.

US$15.56As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (51.72%)
Div yield —
ROE (222.07%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.99
PE TTM —
TSR TTM (17.23%)
Mkt cap US$10.34M
ROIC (113.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
(4.52%)
(91.17%)
Hold 5|10|4|11|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.36
0.40
0.40
0.44
35.91%
35.48%
20.70%
20.42%
Revenue$M
0.668
0.656
0.692
0.702
14.72%
11.97%
14.02%
9.45%
Peers (US$10.34M)
Cap (US$)
PE
10.24M
—
8.604M
—
Capital
TTM
5Y
10Y
Leveragex
1.267
0.068
0.073
EBIT/Intx
10.94
0.065
0.081
Own earn%
(0.07)
(76.16)
(68.74)
Sh yield%
41.22
32.35
28.27
Owners
Insiders/Inst%
2.22
51.94
Short interest%
1.01
SBC / revenue%
0.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
0